Parkinson's Disease Trial, By Invitation NCT06642519 Sponsor: University of Toronto Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, By Invitation

NCT06642519
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been diagnosed with Parkinson's disease and meet the standard medical requirements for a type of brain surgery called deep brain stimulation (DBS) on both sides of the brain.
  • People who experience severe "freezing of gait" (a sudden inability to move the feet when walking) when their Parkinson's medication is not working well, and whose freezing only partially improves after taking levodopa (a common Parkinson's medication) — confirmed by a witnessed freezing episode during a medication test before surgery.
  • People whose freezing of gait has been both reported by the patient or a caregiver and directly observed by a doctor or examiner in a clinical setting.
  • People who are able to give informed consent and are willing and able to follow the study requirements.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have previously had an ischemic stroke (a blockage cutting blood flow to the brain), bleeding inside the brain, or a growth or mass inside the skull.
  • People who have had any previous brain surgery.
  • People who have other medical conditions that could affect or interfere with the study assessments (confirm with trial site).
  • People who do not experience freezing of gait when their Parkinson's medication is working, as this group may already be manageable with current standard treatments.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
University of Toronto
Registry
ClinicalTrials.gov
Start date
10 April 2025
Est. completion
30 October 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Number and Duration FOG episodes

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov